Position in LXEO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,686,500
-$18,750,250 QoQ
Shares Held
4,475,000
0.0% QoQ
Ownership
5.70%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vestal Point Capital, LP holds $2,697,459,670 across 67 Biotechnology names. LXEO ranks #34 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,375,000 | $230,968,750 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
3,575,000 | $201,951,750 | |
| 3 | ABVX |
Abivax S.A.
|
1,500,000 | $167,025,000 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
2,275,000 | $142,642,500 | |
| 5 | ELVN |
Enliven Therapeutics, Inc.
|
3,250,000 | $127,400,000 | |
| 6 | BCAX |
Bicara Therapeutics Inc.
|
5,425,000 | $107,903,250 | |
| 7 | NRIX |
Nurix Therapeutics, Inc.
|
6,500,000 | $100,750,000 | |
| 8 | APGE |
Apogee Therapeutics, Inc.
|
1,100,000 | $92,587,000 |
All Filings in LXEO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,686,500 | 4,475,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $44,436,750 | 4,475,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,580,000 | 3,250,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,977,207 | 3,228,161 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,942,784 | 1,136,249 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,896,000 | 1,200,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,684,000 | 850,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,473,600 | 840,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,744,000 | 175,000 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||